IONS amended Form 144/A: insider sold 14,862 shares

IONS amended a Form 144 filing reporting secondary sales of common stock by Frank Bennett.

Rhea-AI Filing Summary

IONS amended a Form 144 filing reporting secondary sales of common stock by Frank Bennett. The amendment lists sales of $684,264 for 8,977 shares on 01/16/2026 and $487,898 for 5,885 shares on 01/30/2026.

The filing also lists securities available to be sold including 65,089 shares tied to an option exercise (grant date 01/03/2022) and 20,000 restricted stock units (grant date 01/15/2017), as shown in the "Securities To Be Sold" section.

Insights

Corporate Governance Counsel

Amendment shows reported insider sales and remaining equity instruments.

The amendment documents completed dispositions by Frank Bennett totaling $1,172,162 across 01/16/2026 and 01/30/2026, and lists option- and RSU-derived shares that may be sold.

These are secondary transactions by an insider; timing and further sales depend on holder decisions and any transfer restrictions noted in company equity plans.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did IONS' amended Form 144/A report about Frank Bennett's transactions?

The amendment reports two completed sales by Frank Bennett: 8,977 shares sold for $684,264 on 01/16/2026 and 5,885 shares sold for $487,898 on 01/30/2026. The filing lists these transactions as secondary sales.

Does the filing show other securities that may be sold for IONS?

Yes. The filing's "Securities To Be Sold" section lists 65,089 shares from an option exercise (grant date 01/03/2022) and 20,000 restricted stock units (grant date 01/15/2017), indicating additional equity instruments identified in the amendment.

Did IONS receive proceeds from the reported sales in the Form 144/A?

The amendment shows sales by an insider (Frank Bennett) with aggregate proceeds reported for each transaction, indicating these were secondary sales; the filing does not state that the issuer received proceeds from these transactions.

What are the dates of the transactions reported in the amendment for IONS?

The reported sale dates in the amendment are 01/16/2026 for 8,977 shares and 01/30/2026 for 5,885 shares. Grant dates for listed equity instruments are 01/03/2022 and 01/15/2017.

How much total cash did Frank Bennett's reported sales generate in the amendment?

The two sales reported generated a combined $1,172,162 in proceeds: $684,264 and $487,898, as shown next to each transaction in the amendment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 05:52 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK	0001073387
Filer CCC	XXXXXXXX
Previous Accession Number Of The Filing	0001972481-26-000034
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer	IONIS PHARMACEUTICALS INC
SEC File Number	000-19125
Address of Issuer	2855 GAZELLE COURT CARLSBAD CALIFORNIA 92010
Phone	7609319200
Name of Person for Whose Account the Securities are To Be Sold	BENNETT C FRANK
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	85089	7056227.00	161974393	03/03/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/03/2022	Option Exercise	Issuer			65089	03/03/2026	Cash
Common Stock	01/15/2017	Restricted Stock Units	Issuer			20000	01/15/2017	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Frank Bennett 2855 Gazette Ct Carlsbad CA 92010	Common Stock	01/30/2026	5885	487898.00
Frank Bennett 2855 Gazette Ct Carlsbad CA 92010	Common Stock	01/16/2026	8977	684264.00

144/A: Remarks and Signature

Remarks	This form amends the 144 filed on 2/2/26 to update the date of the transactions reported on such 144 from 2/2/26 to 3/3/26.
Date of Notice	03/03/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Luca Lotito, as a duly authorized representative of STIFEL, as attorney-in-fact for Frank Bennett
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)